CORONA Main Coronavirus thread

Heliobas Disciple

TB Fanatic
We hear from Geert, but not about the new outbreaks...


(fair use applies)


Q&A #10: Unvaccinated and Fearless
Geert Vanden Bossche
Jan 5, 2022

Question:

Please ask Geert to address the unvaccinated:

- What do we need to do during the waves?
- Is my unvaccinated child safe with other vaccinated students at school?
- Should we be taking prophylactics?


Answer:

The situation for the unvaccinated is now becoming increasingly difficult because of unjustifiable discrimination. However, I keep saying that the unvaccinated should now less and less worry about their health. Provided they were gradually increasing their contacts, their innate immune system should be well trained by now. Training will only pay off provided you’re in good health and you respect the rules (!) of a healthy lifestyle (which should be well known by now).

So, ‘yes’ even contacts with HEALTHY vaccinees should become less of a problem. It is critical though that people take their supplements (certainly vit C, Zinc) as soon as they don’t feel 100% fit. And keep taking your vitamin D during winter. Regular use of ginger and curcuma are a good idea too! Avoid large and frequent gatherings but make sure your immune system stays trained (so regular contacts are key!).

Last, but not least: mental health is critical, make sure you are in good company and do not fall victim of fear!

More Q&A on www.voiceforscienceandsolidarity.org
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Newly Obtained AstraZeneca Documents - Did you think the mRNA vaccines were the only ones to accumulate in organs? Think again.
More great work from ICAN

NE - nakedemperor.substack.com
Jan 3

The AstraZeneca vaccine has all but disappeared from the UK after it was found to cause blood clots. Nevertheless, its CEO, Pascal Soriot, was knighted last month and said vaccine concerns were overblown.

The vaccine was different to the Pfizer or Moderna vaccines because it was a viral-vector vaccine (similar to Johnson & Johnson’s Janssen) instead of a mRNA one. Whilst the mRNA vaccines used RNA, protected in a lipid nanoparticle, the viral-vector vaccines encoded the genetic instructions to build the coronavirus’ spike protein in DNA. DNA is more stable as it is double-stranded whilst RNA is only single stranded.

So, AstraZeneca took these DNA genetic instructions and placed them inside another virus - a chimpanzee adenovirus. This adenovirus had been modified so that it could enter human cells but not replicate inside them or cause disease. However, once in a human cell, it could deliver its payload - the DNA instructions.

The DNA is pushed into the nucleus of the human cell where the instructions can be read. Using these instructions, the nucleus of the cell creates messenger RNA (mRNA) before pushing it out for other cell molecules to ‘read’.

Understanding messenger RNA and other SARS-CoV-2 vaccines | MDedge  Hematology and Oncology

Now we are at a similar point to the Pfizer and Moderna vaccines, except there aren’t any potentially harmful lipid nanoparticles floating around, just an attenuated chimpanzee virus, that we probably don’t know the long term implication of either.

So, as with the Pfizer and Moderna vaccines, the AstraZeneca vaccine has now asked the human cell to begin translating the mRNA and build spike proteins. These coronavirus spike proteins are built and expressed on the outside of the human cells which then cause an immune response. Antibodies are trained to recognise the spikes and killer T cells try to destroy any cells containing these new instructions.

Remember these are human cells which the vaccine is training your body to attack and kill. We are constantly growing new cells to replace destroyed ones but some, for example cardiac cells, never regrow. So, ideally you don’t really want to be killing these off and training the body to attack them in the future.

Maybe, if the vaccine only stayed at the injection site and just transfected muscle cells in your arm that would be ok but as we have seen with the Pfizer documents (that they wanted hidden for 75 years) this didn’t happen.

But maybe the AstraZeneca vaccine did stay where it was meant to and didn’t travel all round the body?

Unfortunately, this is not the case. Similar to the FDA, the Medicines and Healthcare Products Registry Agency (MHRA) weren’t exactly transparent with the AstraZeneca documents. Fortunately, ICAN, who were instrumental in getting the Pfizer documents released, have been on the case, pressuring the MHRA with Freedom of Information requests.

After approximately eight months of the MHRA threatening to deny ICAN’s requests, they finally released 166 pages of records yesterday.

ICAN was forced to request the documents from the MHRA because the AstraZeneca vaccine was never licensed in the US and so all documents held by the FDA are exempt from disclosure.

After an initial review of the documents, ICAN discovered disturbing information concerning the biodistribution of the vaccine. The documents contained a study which was undertaken on mice and showed that, like the mRNA vaccines, the viral-vector DNA did not remain at the injection site. Instead it accumulated in organs all around the body, specifically the sciatic nerves, bone marrow, liver, lungs and the spleen.

Other revelations, discovered by ICAN, include documents showing that AstraZeneca was forced to amend its vaccine data sheet, in early 2021, due to conclusions that it was causing anaphylaxis shock in some people.

Another “shocking revelation” from the documents was a “heavily redacted discussion of two individuals who developed serious immune-mediated neurological demyelinating conditions following vaccination.” The documents say that there was no evidence of a causal relationship but the adverse event was then added as an important potential risk in the vaccine’s risk management plan.

ICAN are expecting more documents to be released in the next few weeks but in the meantime I will take a more in-depth look at the current tranche.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Ivermectin's Mechanism of Action Against SARS-CoV-2 Described
SHAME on the hospital systems that systematically denied patients (and their begging families) this FDA-approved, Nobel prize winning, wonder drug.

Peter A. McCullough, MD, MPH™
Jan 2

By JOHN LEAKE

Researching our book—The Courage to Face COVID-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex—was often a distressing and maddening experience. The systematic lying about hydroxychloroquine to suppress its use in the outpatient setting was infuriating. However, for me, the most upsetting stories were about people who died in hospital after being systematically denied ivermectin. The sheer brutality of hospital chiefs and their attorneys, who fought tooth and nail against the administration of ivermectin to dying patients, must surely be the most morally repugnant story in modern medical history.

As we document in our book, Drs. Pierre Kory, Paul Marik, and Tess Lawrie were on the front line of fighting for ivermectin in the hospital setting. Drs. Jean-Jacques and Juliana Cepelowicz Rajter published their seminal (ICON) study in the October 12, 2020 edition of the CHEST journal of pulmonary medicine. The investigative journalists, Michael Capuzzo and Mary Beth Pfeiffer, did a splendid job of covering this story in real time. All of the above are heroic figures of great intellectual and moral discernment to whom we should all be grateful.

Many patients who were fortunate enough to prevail in court and receive ivermectin enjoyed an astonishing improvement of their condition within 24 hours of receiving their first dose—a recovery that struck family members as miraculous.

In listening to their stories, I often asked myself: “How on earth could this substance (macrocyclic lactone)—derived from a bacteria (Streptomyces avermectinius) found in a soil sample on a golf course in Japan—possibly work such miracles?” Truly these testimonies struck me as the most wondrous stories I’d ever heard, and I occasionally asked myself if the recoveries observed were a fluke or the result of some other unknown factors.

To be sure, we already knew from in vitro and from prior studies that ivermectin had demonstrated potent anti-viral activity, but the precise cause of action was unknown. Now, thanks to a study recently published by a research team at MEPHI, Aix-Marseille Université, we have a highly plausible description of ivermectin’s mechanism of action against the SARS-CoV-2 spike protein.

In order to understand this mechanism, the reader must first understand that the SARS-CoV-2 Spike Protein Induces Hemagglutination—i.e., a reaction that causes clumping of red blood cells. A glycoprotein on the viral surface, namely hemagglutinin, interacts with red blood cells, leading to the clumping of red blood cells and the formation of a lattice.

As the Aix-Marseille team documents in their study: IVERMECTIN blocked HEMAGGLUTINATION when added to RED BLOOD CELLS prior to spike protein and reversed HEMAGGLUTINATION when added afterward.

By reversing the clumping of red blood cells, ivermectin enabled the dying patient’s proper respiratory function to return, thereby generating his or her astonishing recovery.

If the Aix-Marsaille team’s findings are correct—and we have no reason to doubt that they are—they provide the final validation and vindication of the dying patients and their families who literally begged for the wonder drug.

SHAME on the hospital administrators and their thuggish attorneys who denied the countless dying wishes. SHAME on the federal health officials who propagated the LIE that Ivermectin was merely a “horse de-wormer.” SHAME on the useful idiot media pundits such as CNN broadcasters and Late-Night Comedy hosts who flooded the zone with this foul lie.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


XBB.1.5 strain is dominant in the US after cases doubled in just a week, and could quickly start circulating in Israel; on plus side, variant-bolstered vaccines expected to help
By Nathan Jeffay
3 January 2023, 11:14 pm

COVID-19 experts around the world are watching with concern as the XBB.1.5 subvariant spreads like wildfire in the United States.

There aren’t yet confirmed cases in Israel. But some 41 percent of American cases are now categorized as XBB.1.5, doubling the number of diagnoses in just a week, making the strain dominant. And so, with significant travel between the US and Israel, it’s expected to only be a matter of time until it arrives in the Holy Land.

If it does, it could shake the relative COVID calm the country is enjoying now, with around 1,000 new confirmed cases
Nothing like XBB.1.5 has been seen since late 2021, according to immunologist Dr. Yariv Wine of Tel Aviv University.

“It seems to be faster spreading than any other variant since Omicron emerged in November 2021 and then spread fast in early 2022,” Wine commented. “Virologists are calling it ‘a hell of a variant’ because it’s so transmissible.”

Dr. Eric Feigl-Ding, an epidemiologist and chief of the COVID Risk Task Force at the New England Complex Systems Institute, has called XBB1.5 a “super variant.”

XBB.1.5, which is mutated from the original Omicron strain, appears to be spreading faster than others because it is better at attaching itself to human cells.

“A mutation in the virus is located at the site where it binds to the human cells,” said Wine. “To effectively infect humans, the virus needs to bind to cells, and XBB.1.5 seems to do this very tightly.”

However, he said that its ability to spread may be exaggerated by the latest statistics from the US, as they follow a season of Christmas gatherings and parties during which social contact is higher than normal.

There are no indications that the variant is more severe than others, or that it involves different symptoms, Wine said, adding: “We actually have the tool kit to deal with this, in the form of bivalent vaccines.”

These are the vaccines that have been tweaked to respond better to later variants, which are available in many countries, including Israel.

The New England Journal of Medicine recently published a research letter, concluding that compared to people who received regular vaccines, “persons who received the BA.5-containing bivalent booster had better neutralizing activity against all Omicron subvariants.”

Wine said: “There are indications that the bivalent booster gives better protection against all Omicron subvariants. And while we don’t know yet how well it does against the latest variant, from what we know so far there is no reason to think it will be different.”

Vaccines aren’t expected to halt infection, but are expected to limit severity.

“As such, if vulnerable people are not boosted in the last four plus months they are recommended to get the bivalent booster,” said Wine. “This can reduce the number of severe cases.”
 

Heliobas Disciple

TB Fanatic
(fair use applies)


CDC Finds Hundreds of Safety Signals for Pfizer, Moderna COVID Vaccines

Information obtained through a Freedom of Information Act request reveals the Centers for Disease Control and Prevention identified hundreds of safety signals for the two most widely administered COVID-19 vaccines.


By The Epoch Times

By Zachary Stieber

The Centers for Disease Control and Prevention (CDC) has identified hundreds of safety signals for the two most widely administered COVID-19 vaccines, according to monitoring results obtained by The Epoch Times.

Bell’s palsy, blood clotting and death were among the signals flagged through analysis of adverse event reports submitted to the Vaccine Adverse Event Reporting System (VAERS).

The CDC, which runs VAERS with the U.S. Food and Drug Administration (FDA), describes it as “the nation’s early warning system” for vaccine issues.

The CDC’s primary analysis compared the reports made for specific events suffered after receipt of a Moderna or Pfizer COVID-19 vaccine to the reports lodged following vaccination with any other vaccine, or all non-COVID-19 vaccines.

The type of analysis is known as proportional reporting ratio (PRR).

Safety signals mean a condition may be linked to a vaccine. Signals require further analysis to confirm a possible link.
The CDC analysis was conducted on adverse events reported from Dec. 14, 2020 to July 29, 2022.

The Epoch Times obtained the results through a Freedom of Information Act request after the CDC refused to make the results public.

VAERS is a passive reporting system that accepts reports from anybody, but most are lodged by healthcare professionals, who were told during the pandemic they were required to lodge reports if post-vaccination issues cropped up.

People who lodge false reports face penalties.

Reports do not prove causality or a link between an event and a vaccine. At the same time, studies show that the number of reports is often an undercount of the actual occurrence of post-vaccination events.

‘Onus is on the regulators’

The CDC and FDA said in operating procedure documents that officials would monitor VAERS to identify “potential new safety concerns for COVID-19 vaccines,” with the CDC performing PRR analysis.

The CDC has issued multiple false statements on the data mining, but ultimately acknowledged it did not start performing the monitoring technique until 2022 — more than one year after the Pfizer and Moderna vaccines were authorized.

PRR involves comparing the incidence of a specific adverse event after a specific vaccine to the incidence after all other vaccines.

A signal is triggered when three thresholds are met, according to the CDC: a PRR of at least two, a chi-squared statistic of at least four and three or more cases of the event following receipt of the vaccine being analyzed. Chi-squared tests are a form of statistical analysis used to examine data.

The results obtained by The Epoch Times show that there are hundreds of adverse events (AEs) that meet the definition, including serious conditions such as blood clotting in the lungs, intermenstrual bleeding, a lack of oxygen to the heart and even death. The high numbers, particularly the chi-squared figures, concerned experts.

For many of the events, “the chi-squared is so high that, from a Bayesian perspective, the probability that the true rate of the AE of the COVID-19 vaccines is not higher than that of the non-COVID-19 vaccines is essentially zero,” Norman Fenton, a professor of risk management at Queen Mary University in London, told The Epoch Times in an email after running the numbers through a Bayesian model that provides probabilities based on available information.

There was a probability of less than 0.5% that the rate of hepatic cirrhosis, for instance, was less following COVID-19 vaccination than non-COVID vaccination. For myocarditis or heart inflammation, in the 12- to 17-year-old group, the probability was close to zero.

The CDC’s results also showed that a much higher proportion of events after COVID-19 vaccination were serious.
For adults, for instance, the proportion was 11.1%, compared to 5.5% for after non-COVID vaccines.

Additionally, the proportion of deaths for adults was 15.4% after COVID-19 vaccination, much higher than the 2.5% after other shots.

“The onus is on the regulators to come up with some other causal explanation for this difference if they wish to claim that the probability a COVID vaccine AE results in death is not significantly higher than that of other vaccines,” Fenton said.

The CDC and FDA did not respond to requests for comment.

A CDC spokesperson previously told The Epoch Times in an email that the PRR results “were generally consistent with EB data mining, revealing no additional unexpected safety signals.”

The agency’s records office, in a letter accompanying the results, said that the results “generally corroborated findings from Empirical Bayesian (EB) data mining,” a method employed by the FDA.

The FDA has refused to release the EB mining results.

cdc prr results


A portion of the CDC’s PRR results. The full results can be downloaded at the end of this article.


‘Should be taken seriously and investigated’

U.S. health officials have been cautious in tying adverse events, or side effects, to the COVID-19 vaccines.

But they have acknowledged that some side effects are caused by the Moderna and Pfizer vaccines — both of which utilize messenger RNA (mRNA) technology — including myocarditis and a related condition called pericarditis.

Some age groups are actually at higher risk of myocarditis and pericarditis after vaccination than after COVID-19 infection, leading a growing number of experts to warn against vaccinating certain people.

The newly obtained PRR results returned more than 500 adverse events larger than myocarditis and pericarditis.

“We know that the signal for myocarditis is associated with something that is caused by the mRNA vaccines, so it’s more than reasonable to say that anything with a signal larger than myocarditis/pericarditis should be taken seriously and investigated,” Josh Guetzkow, an Israeli professor who trained in statistics at Princeton University and has been studying VAERS data during the pandemic, told The Epoch Times via email.

The CDC and FDA said in their operating procedures that safety signals would be “reviewed as appropriate.”

“The pattern or trend of PRR and data mining results over a period of time (e.g., several weeks) will be monitored before initiating a clinical review. Other factors, such as clinical importance, whether AEs are unexpected, seriousness, and whether a specific syndrome or diagnosis is identified rather than non-specific symptoms will be considered in determining if clinical review will be performed,” the documents stated.

If a clinical review was triggered, that would include reviewing reports and associated medical records regarding the adverse event, confirming time from vaccination to symptoms onset and other work.

The FDA recently revealed that out of four signals identified for older individuals after Moderna or Pfizer vaccination, three were ruled out with further analysis, but one — pulmonary embolism — continued meeting the criteria.
Pulmonary embolism was identified as a signal in the PRR analysis for individuals as young as 12.

Download the files

The results of the analysis are in Excel sheets. The results can be downloaded from the links below. Tables one and two weren’t provided.
Reprinted with permission from The Epoch Times.

Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


China admits its Covid deaths are 'huge' and 70% of Shanghai's 25m residents have been infected as Beijing threatens retaliation against Western nations over restrictions on air passengers
By Chris Jewers
Published: 04:42 EST, 3 January 2023 | Updated: 10:50 EST, 3 January 2023

  • Beijing abruptly loosened its draconian zero-Covid approach last month
  • But a spike in cases quickly overwhelmed hospitals and crematoriums
  • Now officials are finally starting to admit to the high number of cases, while experts in the West have suggested the country could see 9,000 daily deaths
Chinese officials have admitted that the country's total number of Covid-related deaths is 'huge', with one doctor saying as many as 70 percent of Shanghai's 25 million residents may have been infected.

The steep rise in infections came after Beijing's hardline 'zero-Covid' approach was abruptly ended last month, quickly overwhelming hospitals and crematoriums.

In a rare admission, health officials said on TV that the country was seeing an increase 'in the critical cases or the fatalities'. However, in an attempt to play down the situation, they claimed that the surge was in line with other countries.

Beijing also criticised nations that now require Chinese passengers to show a negative Covid test before entering - that include the UK and the US - warning it could take 'countermeasures' in response.

Yesterday, China's president Xi Jinping finally admitted the mistakes of his draconian zero-Covid policy which failed to contain the virus and sparked the country's first widespread mass protests in decades.

The premier acknowledged 'unprecedented difficulties and challenges' in his New Year's Eve address to the nation and said it was 'only natural' that his harsh lockdown measures were met with resistance.

Xi dropped the zero-Covid measures on December 7 but his new strategy of living with the virus has caused infections to skyrocket, with infections currently peaking in Beijing. In the first 20 days of December, the government's top health authority estimates a staggering 248 million people - equivalent to 18 per cent of the population - contracted the virus.

China maintains that around 5,000 of its citizens have died to the virus since it first broke out in the country at the end of 2019. Experts suggest it could see 9,000 death per day in the on-going wave sweeping the country.

Jiao Yahui, a National Health Commission official, in a rare admission told state broadcaster China Central Television: 'We have a huge base, so what people feel is that the severe cases, the critical cases or the fatalities are increasing.

'As far as this wave is concerned, what people have felt is the absolute number, not the low percentage [of deaths to total infections]. Relative to the rest of the world, the infection peaks we are faced with across the country are not unusual.'

Tong Zhaohui, a vice-president of Chaoyang Hospital in Beijing, agreed that the number was large but said the relative percentage of deaths may still be low. 'Think how many people around you have been infected but how many have developed critical cases or pneumonia. I think everyone has the idea,' he said.

Chen Erzhen, vice president at Ruijin Hospital and a member of Shanghai's Covid expert advisory panel, estimated that the majority of the city's 25million people may have been infected.

Now the spread of the epidemic in Shanghai is very wide, and it may have reached 70 per cent of the population, which is 20 to 30 times more than [in April and May],' he told Dajiangdong Studio, owned by the Communist Party mouthpiece People's Daily. If correct, it would suggest 17.5 million people have been infected in the city alone.

Shanghai suffered a gruelling two-month lockdown from April, during which more than 600,000 residents were infected and many were forced to isolate in quarantine centres.

But now the Omicron variant is spreading rapidly across the city.

In other major cities - such as Tianjin, Chongqing and Guangzhou - Chinese health officials have suggested that the wave has already peaked.

In Zhejiang province, near Shanghai, disease control authorities said that infections were peaking, with one million new cases in recent days.

Dr Chen said that his Shanghai hospital was seeing 1,600 emergency admissions every day - double the number prior to restrictions being lifted. Some 80 per cent of them are Covid patients.

He claimed that more than 100 ambulances arrive at the hospital every day and around half of emergency admissions are patients over the age of 65.

Elderly Covid patients were found crammed in hospital corridors in Shanghai, coughing, groaning, and gasping for breath.

At two hospitals in the city, hundreds of mostly elderly patients lay on wheeled stretchers in public areas as emergency wards filled beyond capacity.

At Tongren Hospital in downtown Shanghai, the corridors overflowed with dozens of elderly patients lying on beds hooked up to IV drips. Some patients wore oxygen masks attached to bedside canisters.

A middle-aged woman in a face mask lifted a flask to the parched lips of a man hooked up to an oxygen cylinder.

Near her, a medical worker wearing blue scrubs and a face visor attended to a grey-haired woman in a red jumper as she shivered under a blanket.

In another hospital, arguments broke out between two people waiting for drips with one woman telling an older man: 'I was here first. I'm here to get a needle too.'

In Huashan Hospital, younger relatives stood over elderly patients to shield them from crowds of people as they waited for treatment.

Doctors and nurses at hospitals in multiple cities say they have continued to treat patients despite testing positive for the virus themselves.

Despite the explosion of infections, Beijing has taken issue with countries imposing restrictions on Chinese arrivals.

The US, Canada, France and Japan are among several countries that now require Chinese travellers to show a negative Covid test before arrival.

In the UK, passengers from the Chinese mainland — apart from Hong Kong — have to present a negative lateral flow or PCR test before boarding any flight to Britain.

Ministers also plan to test a 'sample' of passengers on arrival in the UK to check for variants — such as XBB.1.5, which has been nicknamed 'the Kraken'.

But people coming from China will be allowed to refuse a second PCR test if they choose, raising the risk they could be positive and go undetected.

And, in stark contrast to other countries, passengers who test positive on arrival will not have to self-isolate.

A Department of Health and Social Care spokesperson said: 'We encourage people at the border to take a test to help themselves, their families and wider knowledge on Covid.

'However the testing is optional and people can decline if they wish to do so.'

Asked if passengers who test positive would be required to quarantine, Transport Secretary Mark Harper told LBC: 'No, because what we are doing is we are collecting that information for surveillance purposes.'

China's foreign ministry spokeswoman Mao Ning said: 'Some countries have taken entry restrictions targeting only Chinese travellers. This lacks scientific basis and some practices are unacceptable.'

She warned that China could 'take countermeasures based on the principle of reciprocity'.

In late December, Beijing said inbound travellers would no longer be required to quarantine, sending many Chinese people rushing to book trips abroad.

Countries have cited China's lack of transparency around infection data and the risk of new variants emerging as reasons to restrict travellers.

China recorded only 22 Covid deaths since December, after dramatically narrowing the criteria for classifying such deaths.

But last week Ms Jiao insisted that China had always published data 'on Covid-19 deaths and severe cases in the spirit of openness and transparency'.

She added: 'China has always been committed to the scientific criteria for judging Covid-19 deaths, from beginning to end, which are in line with the international criteria.'

French Prime Minister Elisabeth Borne defended the tests, saying: 'We are in our role, my government is in its role, protecting the French.'

Starting on Wednesday, anyone flying from China to France will have to present a negative virus test taken within the previous 48 hours and be subject to random testing on arrival.

Meanwhile, the British Government will shortly set out full details regarding new rules for travellers entering the UK from China, Downing Street said.

From January 5, travellers from China into England will be required to show a negative Covid-19 test before departing.

Downing Street indicated that details for travellers from Hong Kong would also be set out soon.

The Prime Minister's official spokesman said: 'We're working on the final details of the implementation of the policy, and that includes on Hong Kong, and we will update in due course.'

He said that the Government was in discussions with Chinese officials regarding the new policy, but that he was not yet aware of any 'significant improvement' in Chinese information-sharing at this point.

Downing Street rejected any suggestion that the new rules for Chinese travellers could signal a wider change for visitors travelling to the UK from countries with high rates of Covid-19.

The Prime Minister's official spokesman said: 'A part of the reason for this was because of a lack of comprehensive health information being shared.

'We're working with the Chinese government to encourage them - we're not alone in this - to get more information from them.'

Some Canadian experts have questioned the effectiveness of the testing. Kerry Bowman, assistant professor at the University of Toronto's Temerty Faculty of Medicine, said people can test positive long after entering the country.

The requirement is 'not based on science at this point', he said after Canada announced measures last weekend.

Chinese officials are expecting infections to surge in the countryside later this month as millions of people travel back to their hometowns for the Lunar New Year.

Ms Jiao said that dealing with the expected peak in rural areas would be an 'enormous challenge'.

She added: 'What we are most worried about is in the past three years nobody has returned home for Lunar New Year but they finally can this year.

'As a result, there may be a retaliatory surge of urban residents into the countryside to visit their relatives, so we are even more worried about the rural epidemic.'

She also acknowledged pressure on hospital emergency departments and promised that authorities would coordinate medical resources to ensure treatment of patients in underfunded areas.
Yesterday president Xi broke his silence on his sudden policy pivot last month, saying that China is now in a new phase of Covid control which is 'optimised' to protect lives and the economy.

He added: 'Since Covid-19 struck, we have put the people first and put life first all along. With extraordinary efforts, we have prevailed over unprecedented difficulties and challenges, and it has not been an easy journey for anyone.

'We have now entered a new phase of Covid response where tough challenges remain.'

He added: 'What matters is that we build consensus through communication and consultation. 'Let's make an extra effort to pull through as perseverance and solidarity mean victory.'

The speech was a major shift from the celebratory tone in October when he secured a third term in power at his party congress.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


World Health Organisation warns XBB.1.5 is the 'most transmissible' Covid variant yet as 'the Kraken' strain starts sweeping the UK
By David Averre and Joe Davies
Published: 17:27 EST, 4 January 2023 | Updated: 21:11 EST, 4 January 2023
  • There are no signs XBB.1.5 is more deadly than previously dominant variants
  • But the WHO said it is 'concerned about its growth advantage in particular'
  • XBB.1.5 has already taken hold in the US but has now started to spread in UK

A new strain of Covid nicknamed 'The Kraken' is 'the most transmissible subvariant that has been detected yet', according to the World Health Organisation.

The latest subvariant - another spinoff of Omicron officially named XBB.1.5 - has already taken hold in the US where it is thought to be behind roughly 70 per cent of new infections in the worst affected areas and 4 in 10 overall.

Now it has started to sweep across the UK, indicating it has a major growth advantage over rival strains.

But XBB.1.5 appears to be just as mild as its ancestor Omicron and its variants.

Concern about XBB.1.5 is largely based on how it is currently surging in the US, but it has also already been spotted in Britain and other countries around the globe.

Dr. Maria Van Kerkhove, WHO's technical lead for Covid, told a press conference Wednesday: 'We are concerned about its growth advantage in particular in some countries in Europe and in the US... particularly the Northeast part of the United States, where XBB.1.5 has rapidly replaced other circulating variants.

'Our concern is how transmissible it is… and the more this virus circulates, the more opportunities it will have to change.'

Statistics from the US Centres for Disease Control and Prevention (CDC) showed the strain is behind 41 per cent of cases in America.

In the UK meanwhile, data from GISAID and CoVariants.org suggests that XBB.1.5 was responsible for just under 8 per cent of cases in the two weeks to January 2.

But the latest figures from the Sanger Institute, one of the UK's largest Covid surveillance centres, suggests XBB.1.5 is behind up to half of all Covid cases in the worst-hit regions.

The Sanger Institute's research shows 50 per cent of cases in Wirral last week were caused by the 'Kraken'.

XBB.1.5 has also been detected in countries including France, Germany, the Netherlands, Spain, Ireland, Australia, Singapore and India.

Experts are concerned XBB.1.5's rapid rise could be caused by mutations that help it to better infect people and dodge protection from vaccination and prior infections.

Professor Lawrence Young, a virologist at Warwick University, told MailOnline that the emergence of the strain is a 'wakeup call' and could exacerbate the NHS crisis in Britain.

He said: 'The XBB.1.5 variant is highly infectious and is driving increased hospital admissions in New York, particularly among the elderly.

'Waning immunity, more indoor mixing because of the cold weather and lack of other mitigations, such as wearing facemasks, are also contributing to this surge of infection in the US.'

XBB.1.5 has gained 14 new mutations to the virus' spike proteins compared with its ancestor strains, which appear to have given it enhanced antibody-resistance.

This means people who are vaccinated or have had a previous infection are more susceptible to an infection - though not necessarily severe illness.

But what appears to be spooking the WHO is the prospect of XBB.1.5 being the gateway to a scarier variant.

The more infections that occur, the more opportunities the virus has to mutate and evolve.

The F486P vaccines could make it more resistant to antibodies brought on by the Covid vaccine.

Some lab tests have indicated it can better evade jab-induced immunity, although the jury is still out in the real world.

Professor Young said: 'We don't know how this variant is going to behave in the UK, in a population that has been previously exposed to other Omicron variants and where many of the over 50s have had booster shots with a bivalent vaccine.

'Nevertheless, this is a wakeup call — a sharp reminder that we can't be complacent about Covid.

'The threat of XBB.1.5 and other Covid variants further exacerbating the current NHS crisis stresses the need for us to remain vigilant.

'We need to continue to monitor levels of infection with different variants in the UK, encourage those who are eligible to get their boosters shots — why not extend this to the under 50s? — and promote the value of other mitigation measures.'

Not all experts are so concerned, however.

Even if the vaccines do not work perfectly against the variant, immunity is likely to still hold up, with most Brits also having been exposed to former Omicron variants.

High levels of protection against the virus gave ministers the confidence to ditch all Covid measures last year as the country moved to living with the virus.

Dr Simon Clarke, a microbiologist based at the University of Reading, told MailOnline that XBB.1.5's ability to evade immunity has only been observed in the lab.

'So it's difficult to know how this will translate into real life,' he noted.

'It doesn't seem to be causing more serious disease than other circulating variants, which are the most important metrics to watch when tracking Covid,' he said.

Dr Clarke added: 'It will be interesting to see how the situation develops over the coming months as the usual annual wave of flu hospitalisations is usually highest in January and February.'

Professor Francois Balloux, an infectious disease expert based at University College London, told MailOnline: 'It is far from clear XBB.1.5 will cause a massive wave on its own.'

But there has been a resurgence of dire warnings as a winter crisis batters the NHS and a new Covid variant, called XBB.1.5, triggers cases.

Dr Trish Greenhalgh, a primary healthcare expert at the University of Oxford, was asked if individuals should be limiting contacts.

She said: 'Yes they should – or at least they should be limiting their in-person contacts. We have a perfect storm brewing: an NHS on its knees because of huge demand… [and] rapidly rising rates of Covid and flu.'

Dr Greenhalgh, a member of the controversial group Independent Sage, which has advocated tough Covid curbs, said people should meet outside 'where the chance of transmission is only 1/20th that of indoor spaces'.

She added: 'Wear a mask, and ask your colleagues to do the same. Or, of course, meet online.'

Susan Michie, professor of health psychology at University College London, and also a member of Independent Sage, used Twitter to repost a petition calling for the reintroduction of masks in public indoor places. She said those still wearing masks in shops and on public transport, were 'showing social responsibility'.

However, Professor Robert Dingwall, a sociologist from Nottingham Trent University, who advised on the Covid response at the start of the pandemic, said: 'It feels like the climate of fear… is being reignited.'

Professor Carl Heneghan, director of the University of Oxford's Centre for Evidence-Based Medicine, said giving in to calls for the reintroduction of masks would create an escalating risk of further curbs.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Coronavirus found in samples from 96% of flights

By Stephanie Raymond
January 3, 20232:30 pm

If you believe it's now safe to fly without a protective mask, you might want to think again. New research shows the COVID-19 virus has been found on nearly every flight tested.

Scientists who analyzed wastewater samples taken from 29 flights in Kuala Lumpur have found the coronavirus in 28 of them, according to the National Public Health Laboratory Malaysia. Testing on the 29th sample has not yet been completed, per the laboratory.

The samples were taken at international entry points from June through December 2022. During the same time frame, the lab also tested 301 samples from 15 sentinel locations representing each state in the country.

All totaled, "SarsCoV-2 was detected in 288 samples," or 95.7% of all flights, health director-general Dr. Noor Hisham Abdullah said in a statement to Malaysian newspaper Sinar Harian.

The aircraft sewage surveillance process involves systematic sampling and testing for untreated wastewater and sewer contamination. RNA fragments of the SARS-CoV-2 virus are found in the feces of infected individual regardless of health status (symptomatic, asymptomatic, pre-symptomatic, recovered) and can be detected in sewage. This form of the virus is not infectious and can't be transmitted via feces.

The sewage is taken out of the airplane through a septic tank truck to the aircraft waste disposal facility. Once the targeted flights are identified, officials obtain samples of the sewage water before it undergoes treatment and send them to the lab for testing.

Dr. Abdullah said sewage water sampling from aircraft is carried out twice a week.

"For the sewage water surveillance from this aircraft, as many as one liter of sewage water samples are taken from selected aircraft," Abdullah told Sinar Harian.

The testing is continuously carried out by Malaysia's Ministry of Health as supplementary surveillance to identify countries at risk for COVID-19. Abdullah said the surveillance is intended as an early warning and is one of the control measures the country is using in facing the current situation of the coronavirus.

The concentration of a virus in wastewater can paint a picture of how much COVID-19 is present in that community. Testing at airports can help provide context for how prevalent the virus is among international travelers, and provide clues as to what new variants are emerging.

Within the last week, the Center for Disease Control announced it is considering use of wastewater testing at airports, mainly on incoming international flights, to track any emerging new variants as COVID-19 surges in China. Health officials in Australia and the United Kingdom announced similar plans.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Large COVID autopsy study finds SARS-CoV-2 all over the human body
By Rich Haridy
January 04, 2023

In the most comprehensive autopsy tissue study conducted to date, researchers have found traces of the SARS-CoV-2 virus throughout the entire body, from the brain and the heart to the eyes. The findings indicate the virus can cause persistent infections in many parts of the body, months past an initial illness, and support the argument for further research into antiviral drugs as possible treatment for long COVID.

Three years have passed since the emergence of novel coronavirus SARS-CoV-2, and scientists are still working to understand exactly how this virus interacts with the human body. One ongoing mystery is how broadly SARS-CoV-2 infects different organs, beyond the respiratory system.

Several studies, for example, have come to differing conclusions as to whether the neurological effects of COVID are due to the virus directly infecting brain tissue. Most recently, a team from the Stanford School of Medicine closely analyzed post-mortem brain tissue samples from several COVID patients and couldn't find any traces of viral RNA.

That research did, on the other hand, detect significant inflammatory biomarkers, leading to the hypothesis that the short- and long-term neurological symptoms could be due to persistent immune system activity. This hypothesis has been backed up by subsequent autopsy studies finding neuroinflammation in COVID patients.

This new research, led by National Institutes of Health scientists in association with the University of Maryland, autopsied 44 patients who died from, or with, COVID-19. The study focused on harvesting tissue soon after death from a variety of different locations in the body.

"Our focus on short postmortem intervals, a comprehensive standardized approach to tissue collection, dissecting the brain before fixation, preserving tissue in RNA later and flash freezing of fresh tissue allowed us to detect and quantify SARS-CoV-2 RNA levels with high sensitivity by ddPCR [polymerase chain reaction] and ISH [in situ hybridization], as well as isolate virus in cell culture from multiple non-respiratory tissues including the brain, which are notable differences compared to other studies," the researchers write in the new study.

The findings revealed SARS-CoV-2 RNA could be detected in 84 different locations in the body. The highest burden of viral RNA was found in airway and lung tissue, however, the virus was also detected in the brain, gut, heart, kidney, eye, adrenal gland, and lymph nodes.

The tissue tested came from patients at several different stages of infection, from the earliest stages (less than 14 days after symptom onset) up to nine months after the acute disease. The highest viral burden was unsurprisingly found in those patients at the earliest stages of an infection, but 14 of 27 patients beyond the two-week mark still showed the presence of virus in at least one non-respiratory tissue analyzed.

While the study's findings are certainly striking, what they mean is still unclear. All the patients included in the research were older, unvaccinated, autopsied during the first year of the pandemic, and suffered from many comorbidities. So it is unknown whether new variants of virus spread through vaccinated, younger people in similar ways.

Nevertheless, what this study does clearly illustrate is the potential for SARS-CoV-2 to spread through tissues across the entire body, including the brain. And the researchers are now asking whether this could play a role in which patients experience long COVID.

The next step for the research team is to gather postmortem tissue from deceased long COVID patients to understand whether the virus can be found months after an acute illness. This is part of a larger project dubbed RECOVER (Researching COVID to Enhance Recovery).

Alongside the tissue pathology work, the RECOVER project is running a clinical trial testing the efficacy of antiviral Paxlovid in treating long COVID patients. The hypothesis is that if long COVID symptoms are triggered by persistent SARS-CoV-2 infections in certain parts of the body, then trying to eliminate the virus with antivirals should improve those symptoms.

The Paxlovid long COVID trial is set to begin this year and the RECOVER project is slated to run up to four years.

The new research was published in Nature.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


Beds run out at Beijing hospital as COVID brings more sick
Jan 5 2023

BEIJING (AP) — Patients, most of them elderly, are lying on stretchers in hallways and taking oxygen while sitting in wheelchairs as COVID-19 surges in China’s capital Beijing.

The Chuiyangliu hospital in the city’s east was packed with newly arrived patients on Thursday. By midmorning beds had run out, even as ambulances continued to bring those in need.

Hard-pressed nurses and doctors rushed to take information and triage the most urgent cases.

The surge in severely ill people needing hospital care follows China abandonment of its most severe pandemic restrictions last month after nearly three years of lockdowns, travels bans and school closures that weighed heavily on the economy and prompted street protests not seen since the late 1980s.

It also comes as the the European Union on Wednesday “strongly encouraged” its member states to impose pre-departure COVID-19 testing of passengers from China.

Over the past week, EU nations have reacted with a variety of restrictions toward travelers from China, disregarding an earlier commitment to act in unity.

Italy — where the pandemic first exacted a heavy toll in Europe in early 2020 — was the first EU member to require coronavirus tests for airline passengers coming from China, but France and Spain quickly followed with their own measures. That followed the imposition by the U.S. of a requirement that all passengers from China show a negative test result obtained in the previous 48 hours before departure.

China has warned of “countermeasures” if such policies were to be imposed across the bloc.

Still, World Health Organization head Tedros Adhanom Ghebreyesus said Wednesday he was concerned about the lack of outbreak data from the Chinese government.

China has sought to get more of its elderly population vaccinated, but those efforts have been hampered by past scandals involving fake medications and previous warnings about adverse reactions to the vaccines among older people.

China’s domestically developed vaccines are also considered less effective than the mRNA jabs used elsewhere.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


EU urges pre-flight COVID-19 tests on passengers from China
By RAF CASERT
Jan 4 2022

BRUSSELS (AP) — The European Union on Wednesday “strongly encouraged” its member states to impose pre-departure COVID-19 testing of passengers from China, in a move that is likely to upset Beijing and has already been criticized by the global airline industry.

Following a week of talks between EU health experts, the bloc stopped short of agreeing that all 27 member states impose such a travel restriction that members like Italy, France and Spain had already implemented at a national level. Instead, it only urged nations to do so.

China has already vehemently rejected such actions, warning of “countermeasures” if such policies were to be imposed across the bloc.

Even though the EU presidency said in a statement that the member states “agreed on a coordinated precautionary approach,” part of the approach fell short of full agreement.

In the most crucial part of the statement, it said that “the Member States are strongly encouraged to introduce, for all passengers departing from China to Member States, the requirement for a negative COVID-19 test.”

On other issues, the EU said there was full agreement to have passengers wear masks when traveling to and from China and to offer advice on personal hygiene and health issues.

Earlier Wednesday, EU Commission spokesman Tim McPhie had said that the “overwhelming majority of countries are in favor” of imposing testing of passengers from China prior to departure. But the EU apparently could not find agreement to bind them all.

The Chinese government and European health experts have said there is no pressing need for any blanket restrictions on travel since the coronavirus variants emerging from China are already prevalent in Europe.

On Wednesday the International Air Transport Association, which represents some 300 airlines worldwide, lent its powerful voice to the protests.

“It is extremely disappointing to see this knee-jerk reinstatement of measures that have proven ineffective over the last three years,” said IATA Director General Willie Walsh.

“Research undertaken around the arrival of the omicron variant concluded that putting barriers in the way of travel made no difference to the peak spread of infections. At most, restrictions delayed that peak by a few days,” Walsh said.

Still, World Health Organization head Tedros Adhanom Ghebreyesus said Wednesday he understood why numerous countries have recently taken measures against travelers coming from China, given the lack of outbreak data from the Chinese government.

The EU also said it took its approach “especially considering the need for sufficient, reliable data” coming from China. The bloc said it will reassess the situation by the middle of the month, one week after China’s easing of travel restrictions on its citizens becomes official on Jan. 8.

A day after threatening countermeasures, Chinese government spokesperson Mao Ning said Wednesday that “we sincerely hope that all parties will focus on fighting the epidemic itself, avoid the politicization of COVID.”

Still, the EU sought to take some sort of joint action to ensure incoming passengers from China do not transmit any potential new variants to the continent.

Fearful of being caught unawares like at the outset of the global pandemic in early 2020, the EU Integrated Political Crisis Response group wanted quick action, and ended up with encouragement on several issues instead of imposing measures.

Wednesday’s EU Presidency statement also said member states “are encouraged” to carry out random testing of passengers and check waste water from planes arriving from China to see if it contains dangerous variants that are not common in the continent.

Over the past week, EU nations have reacted with a chaotic cascade of national measures to the crisis in China, disregarding an earlier commitment to act in unity before anything else.

Italy — where the pandemic first exacted a heavy toll in Europe in early 2020 — was the first EU member to require coronavirus tests for airline passengers coming from China, but France and Spain quickly followed with their own measures.
 

Heliobas Disciple

TB Fanatic
(fair use applies)


As COVID turns 3, experts worry where the next pandemic will come from – and if we'll be ready
Karen Weintraub, USA TODAY
Wed, January 4, 2023, 12:28 PM EST

For years, public health experts warned of the possibility of an illness spreading across the globe and killing millions. After all, it had happened before.

Measures were in place around the world to spot early signs of a never-before-seen bug with dangerous potential.

That's why on Dec. 31, 2019, China notified the World Health Organization that a novel pathogen was circulating in Wuhan, the most populous city in central China. A day later, in that city of 12 million, a wet market selling live animals was shuttered because of fears it was the source of the virus that would later be named SARS-CoV-2.

Three years later, the risk of a deadly pathogen spreading around the world remains.

Now, in addition to worrying about a virus that might jump from animals to humans, experts are concerned about research accidents and – what should be unthinkable – the possibility of someone intentionally unleashing a highly contagious and lethal pathogen.

A pandemic has long been known to be far riskier for global security than conventional, nuclear or chemical warfare, said Lawrence Gostin, a professor of public health law at Georgetown University and a leading expert in global health.

"We've seen that play out with COVID, and COVID is far from the worst pandemic threat that we face," he said.

Although COVID-19 has killed more than 6.6 million people worldwide, other pandemics have been more lethal. The 1918 flu is estimated to have cost 50 million lives across the globe, and in the 14th century, the Black Death killed 30% to 60% of all Europeans in just four years.

Public health and national defense experts worry the next pandemic will come at an even higher price than this one. And they say the nation needs to be ready.

"It's incumbent on the United States and other countries to be prepared for whatever comes from biology, whether it's from nature or from engineering or a laboratory accident," said Dr. Tom Inglesby, director of the Johns Hopkins Center for Health Security at the Bloomberg School of Public Health.

The next pandemic could be worse

Gostin sees nature as the most likely source of the next pandemic. A highly lethal strain of bird or swine flu could mutate naturally to become contagious to humans. That scenario kept health experts like Gostin awake at night long before COVID-19.

But other causes are possible.

"We have a whole host of threats from lab leaks to bioterror to bioweapons to naturally occurring zoonotic spillovers," said Gostin, author of the 2021 book "Global Health Security: A Blueprint for the Future."

"All of that leads to quite a high probability that we're going to have more frequent pandemic-like threats and we need to take them seriously as a national security threat."

The SARS-CoV-2 virus is the third coronavirus to pose a major health threat, following the first SARS and Middle East respiratory syndrome – both of which are far more lethal. Another coronavirus with the contagious potential of SARS-CoV-2 and the 30% death rate of MERS would threaten the economy, supply chains and the health care system, not to mention human life.

And those are just the direct consequences.

With COVID-19, we're likely to see indirect effects for years as people who skipped routine medical care are diagnosed with more advanced and deadlier cancers and children who missed routine vaccines fall ill with preventable diseases, among other consequences, Gostin said.

"If you think of a far worse pandemic, you can multiply that by ten- or even fiftyfold in terms of the economic and social harms the United States would suffer," he said.

That means the world needs to have a better capacity to fight such threats, not spending money only after the crisis arrives, he and others said.

Right now, only about 5% of the country's health care dollars are spent on public health and preventing the next crisis. "That's a rounding error in the U.S. budget," Gostin said.

The idea of engineering a deadly pathogen that sickens the world sounds like the stuff of science fiction or superhero movies. But it's no longer a fantasy.

Kevin Esvelt, an MIT biologist, said people in his own lab could theoretically assemble a dangerous virus from DNA ordered on the internet for under $1,000.

Once pandemic-capable viruses are identified, thousands of people worldwide have the scientific training to make them from mail-ordered synthetic DNA.

"Imagine a world where you can order weapons-grade plutonium in the mail," he said, "and there are thousands of engineers who have the skills to put together something that might be a bomb."

In less than 100 days last fall and winter, the omicron coronavirus variant spread from southern Africa to the rest of the world, infecting 26% of Americans, Esvelt said, illustrating how fast a pandemic response needs to be.

Esvelt warned Congress earlier this year that pandemic virus identification would make pandemics widely accessible and recently released a 30-page plan preparing for a world in which it's feasible to unleash one.

The risk is real and growing over time as engineering biology becomes easier, said Jaime Yassif, vice president of the Nuclear Threat Initiative's Global Biological Policy and Programs. Still, it's not "trivial to create a biological weapon that would cause significant harm," she said.

COVID-19 made the threat more real, she and others said, by showing how much chaos a global pandemic can sow.

"Some people may have taken note of the impact and paid more attention than before," Yassif said. "It's reasonable to assume that the intentions are already there and they may be growing, and that capabilities are increasingly within reach. That's my rational calculus about why I take it seriously."

The potential for bioterrorism

The global Biological Weapons Convention was enacted in March 1975 to prevent countries from ever developing or producing biological weapons. It has largely held ever since, though a few countries that signed on to the treaty are believed to have or have had secret programs.

The Soviets once tried to engineer Ebola into a more contagious pathogen, for instance, but it didn't work well, said Christine Parthemore, CEO of the Council on Strategic Risks, a nonprofit, nonpartisan security policy institute.

China and Iran may have come right up to the line, if not crossed it, making offensive weapons, she said. Based on U.S. government public assessments, for example, Iran may be using "botulinum toxin that we don't think is for Botox, at least not solely."

"The history is there," Parthemore said. "Countries have engineered pathogens."

The Defense Department initially became interested in mRNA vaccines, which were used to fight COVID-19, as a rapid way to counter state-based biological threats and engineered pathogens, she said.

And the vaccine that proved effective this summer against mpox (formerly known as monkeypox) was developed to counter the possibility that someone might try to unleash its deadlier cousin smallpox on the world.

But the vast majority of countries are unlikely to try to unleash a deadly pathogen, she said, because it would be hard to protect their own people during a massive outbreak.

Still, Parthemore worries nations are losing faith in international institutions and treaties. Russia's war against Ukraine and the United Nations' inability to stop it have weakened international agreements in the eyes of many nations, including those focused on biosecurity.

"The loss of faith in cooperation and the U.N. and collective action and Russia and others acting as they have further degrading the norms we've held onto so dearly for decades – it's pretty scary," she said.
Should research be regulated?

One question is how much regulation should be imposed on scientific work and researchers involved in synthesizing potential pathogens.

Yassif supports "more rules of the road" to safeguard the scientific advances that might be misused by bad actors.

In 2012, the scientific community and others debated research in the U.S. and the Netherlands that explored five mutations making avian influenza more contagious to humans. Some in the virology community defended that research as essential for understanding naturally emerging risks. Yassif and others worry it made creating a global hazard one step easier.

"The systems we have in place are not as broad in scope or as robust as they need to be," Yassif said.

The construction of new biosafety labs also has raised concerns among experts.

Since the start of the COVID-19 pandemic, more than a dozen countries have announced plans to build Level 4 labs, the highest level of security, designed to investigate the most dangerous pathogens.

These labs lack strong international oversight, Parthemore said. "Obviously, if you had an offensive program and you were trying to engineer pathogens in certain ways, a BSL-4 laboratory is where you would do the work," she said. "The lack of transparency in these labs and their proliferation is a huge problem."

It's also too easy to order the building blocks of a pathogen on the internet, Yassif said. Some companies screen orders to make sure they're not selling dangerous DNA sequences to bad actors, but they're not required to do so. "There's probably a sizeable market share that's not being screened, and we're trying to close that gap," she said.

How to prepare for the next one

No single action can reduce the pandemic risk to zero, the experts said.

But there are plenty of options for actions and a "layered defense." Intervening at multiple points in the process a bad actor would use to create a biological weapon will make the world much safer.

Technology can solve the problem created by biology, Esvelt said. He envisions better protective gear, especially for health care and other essential workers, as well as germicidal lights that kill pathogens without harming the people who use the same indoor space. He wants wastewater and air surveillance at airports to detect new pathogens that might have a long incubation period before showing symptoms, as HIV does.

Preparedness isn't just about scientific breakthroughs. It also involves investing in people, said Dr. Raj Panjabi, senior director for global health security and biodefense for the U.S. National Security Council.

For decades, the U.S. has underinvested in those who deliver public and animal health, he said, including epidemiologists, veterinarians, public health nurses and community health workers.

In October, the Biden administration launched what it called a National Biodefense Strategy and Implementation Plan for Countering Biological Threats, Enhancing Pandemic Preparedness, and Achieving Global Health Security.

Panjabi described some of the strategy's goals and timelines in a webinar this fall:
  • Testing: Enable testing for a new pathogen within 12 hours, surge testing within a week and pathogen-specific testing within 30 days
  • Vaccination: A new vaccine should be developed within 100 days, enough manufactured for the entire U.S. population within 130 days, and for high-risk populations around the world within 200 days.
  • Treatment: Drugs should be repurposed within 90 days and new therapeutics developed within 180 days.
"Time is lives in an emergency," he said. "How well we respond depends on how well we prepare."

The administration has asked for $88 billion over the next five years to implement the plan. "Billions to be invested now to save trillions in the future and an incalculable amount of human lives both American and around the world," Panjabi said.

Congress has not yet followed up with enough funding to pursue this agenda.

"It makes no sense that Congress has not taken up the administration’s proposed pandemic preparedness agenda," said Inglesby, who recently co-wrote a proposal for the development of diagnostics in a health emergency. He hopes the money will be allocated soon.

Another disastrous pandemic is not inevitable, he and others said, but prevention requires preparation and forethought.

"Pathogens of various forms are very good at adapting and changing form. But modern science is very good at countering that," Gostin said. "If we're smart and well prepared and invest strongly and robustly in it, we can substantially lower the risk."
 

Heliobas Disciple

TB Fanatic
(fair use applies)


German health minister voices concern over new COVID variant
by Rachel More
Thu, January 5, 2023, 1:36 AM EST·1 min read

BERLIN (Reuters) - Germany's health minister has expressed concern over a new COVID-19 subvariant linked to growing hospitalisations in the northeastern United States, adding that Berlin was watching the situation closely.

As much of the world looks to rising COVID cases in China, infectious disease experts have also been increasingly worried about the highly contagious Omicron XBB.1.5, which made up more than 40% of U.S. cases, official data showed last week.

"Hopefully we get through the winter before such a variant can spread among us," the minister, Karl Lauterbach, wrote on Twitter late on Wednesday.

"We are monitoring whether, and to what extent, XBB.1.5 occurs in Germany."

Seven of the 10 U.S. states to see rising infections and hospitalisations are in the Northeast, in line with higher XBB cases, Dr. Michael Osterholm, an infectious disease expert at the University of Minnesota, told Reuters in a recent interview.
 

Zoner

Veteran Member
My sense is that there is something different happening in China, the UK and Ireland where they are running out of oxygen and deaths are mounting and hospitals are breaking down... than what is happening here in the U.S. with this new outbreak of XBB15.

If XBB15 started here in the U.S., then we should be ahead of what is happening in China and the UK shouldn't we?
So I'm led to think something else is going on over there in the UK and China other than XBB15.
 

psychgirl

Has No Life - Lives on TB
My sense is that there is something different happening in China, the UK and Ireland where they are running out of oxygen and deaths are mounting and hospitals are breaking down... than what is happening here in the U.S. with this new outbreak of XBB15.

If XBB15 started here in the U.S., then we should be ahead of what is happening in China and the UK shouldn't we?
So I'm led to think something else is going on over there in the UK and China other than XBB15.
I agree.

“Something “ is different.
Strange. Just very scary and strange.
 

psychgirl

Has No Life - Lives on TB
Just got my order and started taking it
When DH had Covid pneumonia last December/January I orderd Serrapeptase.

On the second day of taking it he broke out in a tiny, itchy rash from his neck, and down his back to his upper thighs
His hands were swollen with inflamed and horribly itchy hives.
Not an inch of his backside was not covered in the rash. All we could do was slather on the cortisone cream and keep up with Benedryl.

It was awful. I took photos of his backside
He just about scratched his poor hands raw. :(
(His hands remained swollen for a couple of weeks but the rash did go away in a couple of days)

I was at my wits end by this time, drove in tears to CVS for more cortisone cream and talked to the pharmacist; she had no idea but said since that supplement was the only new thing I’d added to his treatment, to discontinue it.
I stopped giving to him.

He’s already “recovered” from the pneumonia part, so we just figured from doing reading that this was the virus working it’s was out of his system.

We will never know for sure which it was, so I’m giving you this story as a heads up.
 

Zoner

Veteran Member
When DH had Covid pneumonia last December/January I orderd Serrapeptase.

On the second day of taking it he broke out in a tiny, itchy rash from his neck, and down his back to his upper thighs
His hands were swollen with inflamed and horribly itchy hives.
Not an inch of his backside was not covered in the rash. All we could do was slather on the cortisone cream and keep up with Benedryl.

It was awful. I took photos of his backside
He just about scratched his poor hands raw. :(
(His hands remained swollen for a couple of weeks but the rash did go away in a couple of days)

I was at my wits end by this time, drove in tears to CVS for more cortisone cream and talked to the pharmacist; she had no idea but said since that supplement was the only new thing I’d added to his treatment, to discontinue it.
I stopped giving to him.

He’s already “recovered” from the pneumonia part, so we just figured from doing reading that this was the virus working it’s was out of his system.

We will never know for sure which it was, so I’m giving you this story as a heads up.
Thank you a bunch and I may just take it sporadically
 

psychgirl

Has No Life - Lives on TB
Thank you a bunch and I may just take it sporadically
It might not have been what caused it but also, I did look up possible side effects and skin issues were listed.

You might try it out and see how it works for you, because also remember…DH was in a fragile. healing stage at the time.

I’m still have the bottle; I’m tempted to try it out myself lol.
It almost causes me PTSD just looking at that bottle
 

momma_soapmaker

Disgusted
When DH had Covid pneumonia last December/January I orderd Serrapeptase.

On the second day of taking it he broke out in a tiny, itchy rash from his neck, and down his back to his upper thighs
His hands were swollen with inflamed and horribly itchy hives.
Not an inch of his backside was not covered in the rash. All we could do was slather on the cortisone cream and keep up with Benedryl.

It was awful. I took photos of his backside
He just about scratched his poor hands raw. :(
(His hands remained swollen for a couple of weeks but the rash did go away in a couple of days)

I was at my wits end by this time, drove in tears to CVS for more cortisone cream and talked to the pharmacist; she had no idea but said since that supplement was the only new thing I’d added to his treatment, to discontinue it.
I stopped giving to him.

He’s already “recovered” from the pneumonia part, so we just figured from doing reading that this was the virus working it’s was out of his system.

We will never know for sure which it was, so I’m giving you this story as a heads up.
Sounds like a herxheimer reaction. It's caused by the body detoxing. As sick as he was, it wouldn't surprise me.
 

Pinecone

Has No Life - Lives on TB

From May, 2021

McDonald’s, White House Partner to Promote Coronavirus Vaccine​

The fast food chain is redesigning its coffee cups to feature art from the national 'We Can Do This' campaign to promote COVID-19 vaccinations.

By Alexa Lardieri
|
May 11, 2021, at 12:23 p.m.


McDonald’s to Promote Virus Vaccine

McDonald's is partnering with the White House to promote coronavirus vaccine information on its coffee cups as America's vaccination rate declines.

The fast food chain announced on Tuesday that it was redesigning its McCafe cups and delivery seal stickers to feature art from the national "We Can Do This" campaign, a slogan created by the Department of Health and Human Services to promote COVID-19 vaccinations across the U.S.

The redesigned coffee cups and stickers will hit stores in July and lead customers to vaccines.gov, where people can learn more about the COVID-19 vaccine and find appointments to receive a shot near them.

"McDonald's is committed to making helpful information accessible to our customers, who are encouraged to share the campaign using #WeCanDoThis to inspire others to learn more about what they can do to help end the pandemic," the company said.

Additionally, later this month, vaccine information will be displayed on the company's billboard above Times Square in New York City.

"We all want to protect ourselves and our loved ones and be together with our communities again. McDonald's is excited to be doing our part for the people we serve, providing them with simple information that can help keep them safe," Genna Gent, vice president for global public policy and government relations, said. "This is a team effort – it takes all of us. We're proud to enter this partnership to provide trusted, independently verified information about COVID-19 vaccines to our customers in the nearly 14,000 communities we serve."

HHS Secretary Xavier Becerra said that, thanks to this partnership, "people will now be able to get trusted information about vaccines when they grab a cup of coffee or order a meal."


"Ending this pandemic requires all of us working together to do our part, including encouraging our friends and family to get vaccinated. This effort will help more people make informed decisions about their health and learn about steps they can take to protect themselves and their communities," Becerra added.

According to the Centers for Disease Control and Prevention, more than 152 million people have received at least their first dose of the COVID-19 vaccine in the U.S., but the vaccination rate has declined from its peak last month.
 

rob0126

Veteran Member
HHS Secretary Xavier Becerra said that, thanks to this partnership, "people will now be able to get trusted information about vaccines when they grab a cup of coffee or order a meal."

Nothing says health like a greasy triple cheese burger, plastic french fries, and a high fructose corn syrup soda...

With so much evidence to suggest the vaccines are murder weapons, to keep pushing them is telling of who the monsters are.(They know exactly what they are doing!!!)

May God bring swift judgment on them all and have mercy on those being suckered into taking the death shots.
 

Zoner

Veteran Member

CDC: New, Highly Infectious COVID Variant Spreading Much Faster in NY, NJ Than US​

A new omicron subvariant that fuses two prior subvariants from the wildly contagious strain that first emerged in South Africa is spreading rapidly in the northeastern United States, CDC data shows

By Jennifer Millman
January 5, 2023 at 1:39 pm

The CDC said the new COVID-19 variant is responsible for 75% of new cases.

A new most transmissible-yet COVID variant has established dominance in the New York area, fueling rising infection rates across the five boroughs as a looming nurses' strike and ongoing concerns about RSV in kids stoke fresh anxiety about the years-long pandemic.

That XBB.1.5 strain, another omicron descendant, is a highly contagious "recombinant" one spawned from two prior, and different omicron subvariants. Those two were considered more transmissible than their predecessors at the time they emerged, and the resulting fusion -- XBB.1.5 -- is believed to be that much more potent in terms of infectiousness.

At this point, the World Health Organization doesn't have any data to indicate it is more lethal or causes more severe cases, but the rate at which it is spreading, especially in the northeastern United States, is raising some questions.

Global health officials are worried about the rapid spread rate -- the number of people infected with XBB.1.5 has been doubling in the U.S. about every two weeks -- according to WHO COVID-19 Technical Lead Maria VanKerkhove.

"It is the most transmissible subvariant that has been detected yet," she told reporters this week. "The more this virus circulates, the more opportunities it will have to change."

And nowhere is XBB.1.5 circulating faster than the northeast, according to CDC data. Its latest update estimates the variant's prevalence in the New York region, which also encompasses New Jersey, Puerto Rico and the Virgin Islands, to be 72.2% but as high as 80.8%, compared with a 40.5% estimated prevalence and 61% high at the national level.

The CDC's Connecticut region, which also includes Maine, Massachusetts, New Hampshire, Rhode Island and Vermont, most of which typically reported lower than national average viral rates through the pandemic, has a slightly higher prevalence. The agency estimates XBB.1.5 could account for up to 86.2% of COVID virus circulating there.

The data are current only through New Year's Eve, meaning the numbers should rise across the board when the CDC next updates its variant data on Friday.

In New York City, health department data shows the rolling case average has fallen from its recent high in early December but is holding at a higher rate than city officials would likely prefer. Current numbers are around where they were in August in terms of new cases. COVID-related hospitalizations and deaths rose this winter in accordance with the case spike, but city health data shows both lines plunging in recent weeks as patients are discharged and recover.

At the state level, Gov. Kathy Hochul's latest COVID update puts the rolling positivity rate at 8.7%, the highest it's been since August. Breakthrough case rates have stabilized, but reinfection rates, especially among the unvaccinated and on Long Island, are rising. Hospitalizations have also been climbing, with Hochul reporting a statewide total of 4,350 as of Wednesday, an increase of nearly 390 over the prior day. More than 400 of those patients are in intensive care units.

The rolling hospitalization rate of 22.26 per 100,000 residents in the state's latest report is the highest it's been since February, health department data show.

Overall, though, the majority of all patients hospitalized with COVID in the state (54.8%) did not have the virus included as one of the reasons for admission. In other words, it was non-severe enough to be detected only via routine testing.

Increased infection rates needn't translate to increases in COVID-linked hospitalizations and deaths, public health and elected officials at all levels of government are quick to stress. Countermeasures like vaccination, frequent hand-washing, getting bivalent boosters and staying home when sick, along with masking, continue to work, they say.

"As we continue to welcome the new year, I urge everyone to remain vigilant and continue to use all available tools to keep themselves, their loved ones and their communities safe and healthy," Hochul said in her office's latest COVID update. "Stay up to date on vaccine doses, and test before gatherings or travel. If you test positive, talk to your doctor about potential treatment options."



 
Top